192 related articles for article (PubMed ID: 26864456)
1. Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.
Zhang Y; Gao H; Liang W; Tang L; Yang Y; Wu X; Yu L; Chen P; Zheng S; Ou H; Li L
BMC Infect Dis; 2016 Feb; 16():76. PubMed ID: 26864456
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
Huang SF; Fung CP; Perng DW; Wang FD
J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.
Tran-To Su C; Ouyang X; Zheng J; Kwoh CK
BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
[TBL] [Abstract][Full Text] [Related]
8. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
[TBL] [Abstract][Full Text] [Related]
9. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
Chen JY; Wei SK; Lai CC; Weng TS; Wang HH
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033501
[TBL] [Abstract][Full Text] [Related]
10. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
[TBL] [Abstract][Full Text] [Related]
11. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
[TBL] [Abstract][Full Text] [Related]
12. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
Yen HL; McKimm-Breschkin JL; Choy KT; Wong DD; Cheung PP; Zhou J; Ng IH; Zhu H; Webby RJ; Guan Y; Webster RG; Peiris JS
mBio; 2013 Jul; 4(4):. PubMed ID: 23860768
[TBL] [Abstract][Full Text] [Related]
13. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
Hirotsu N; Saisho Y; Hasegawa T; Shishido T
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):173-182. PubMed ID: 29284320
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
[TBL] [Abstract][Full Text] [Related]
15. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
Meijer A; Rebelo-de-Andrade H; Correia V; Besselaar T; Drager-Dayal R; Fry A; Gregory V; Gubareva L; Kageyama T; Lackenby A; Lo J; Odagiri T; Pereyaslov D; Siqueira MM; Takashita E; Tashiro M; Wang D; Wong S; Zhang W; Daniels RS; Hurt AC
Antiviral Res; 2014 Oct; 110():31-41. PubMed ID: 25043638
[TBL] [Abstract][Full Text] [Related]
16. Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study.
Kato M; Saisho Y; Tanaka H; Bando T
Influenza Other Respir Viruses; 2021 Jan; 15(1):132-141. PubMed ID: 32677375
[TBL] [Abstract][Full Text] [Related]
17. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
Hu Y; Lu S; Song Z; Wang W; Hao P; Li J; Zhang X; Yen HL; Shi B; Li T; Guan W; Xu L; Liu Y; Wang S; Zhang X; Tian D; Zhu Z; He J; Huang K; Chen H; Zheng L; Li X; Ping J; Kang B; Xi X; Zha L; Li Y; Zhang Z; Peiris M; Yuan Z
Lancet; 2013 Jun; 381(9885):2273-9. PubMed ID: 23726392
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
[TBL] [Abstract][Full Text] [Related]
19. A study on mother-to-fetus/infant transmission of influenza A(H7N9) virus: Two case reports and a review of literature.
Wang J; Xu H; Mu C; Chen C; Guo L; Chen L; Huang JA; Guo Q
Clin Respir J; 2018 Nov; 12(11):2539-2545. PubMed ID: 30126042
[TBL] [Abstract][Full Text] [Related]
20. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
